6.2b

8MM respiratory syncytial virus prevention market to reach $6.2b by 2030

Thanks to the introduction of new monoclonal antibodies and vaccines. According to GlobalData, the respiratory syncytial virus (RSV) prevention market…

- Advertisement -
Ad image
- Advertisement -
Ad image